Jerome III - Claritev Executive COO
| CTEV Stock | | | 39.31 0.83 2.16% |
COO
Jerome III is Executive COO of Claritev
| Age | 59 |
| Address | 115 Fifth Avenue, New York, NY, United States, 10003 |
| Phone | 212 780 2000 |
| Web | https://www.claritev.com |
Claritev Management Efficiency
Return On Tangible Assets is likely to climb to -3 in 2025.
Return On Capital Employed is likely to climb to -0.27 in 2025. At this time, Claritev's
Total Assets are fairly stable compared to the past year.
Non Current Assets Total is likely to climb to about 5.7
B in 2025, whereas
Other Current Assets are likely to drop slightly above 34.4
M in 2025. Claritev's management efficiency ratios could be used to measure how well Claritev manages its routine affairs as well as how well it operates its assets and liabilities.
Similar Executives
Claritev (CTEV) is traded on New York Stock Exchange in USA. It is located in 115 Fifth Avenue, New York, NY, United States, 10003 and employs 2,700 people. Claritev was previously known as
MPLN Old and was traded on NASDAQ Exchange under the symbol
MPLN. Claritev is listed under Health Care Equipment & Supplies category by Fama And French industry classification.
Management Performance
Claritev Leadership Team
Elected by the shareholders, the Claritev's board of directors comprises two types of representatives: Claritev inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Claritev. The board's role is to monitor Claritev's management team and ensure that shareholders' interests are well served. Claritev's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Claritev's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alwyn Heerdan, Vice Development | |
| Melissa Humphrey, Senior Communications | |
| Jason Wong, Senior Relations | |
| Douglas Garis, Executive CFO | |
| Tiffani Misencik, Senior Officer | |
| Michael Kim, Executive Officer | |
| Tara ONeil, Senior Counsel | |
| Travis Dalton, President CEO | |
| Jerome III, Executive COO | |
| Carol Nutter, Senior Officer | |
| Derek ReisLarson, Senior Services | |
Claritev Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Claritev a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Claritev Stock Analysis
When running Claritev's price analysis, check to
measure Claritev's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Claritev is operating at the current time. Most of Claritev's value examination focuses on studying past and present price action to
predict the probability of Claritev's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Claritev's price. Additionally, you may evaluate how the addition of Claritev to your portfolios can decrease your overall portfolio volatility.